NASDAQ:ACOR Shareholder Notice Lawsuit Alleges Misleading Statements by Acorda Therapeutics Inc
The Shareholders Foundation announces that an investor, who purchased NASDAQ:ACOR shares, filed a lawsuit against Acorda Therapeutics.
View full press release